Kai Xu

4.3k total citations
112 papers, 2.8k citations indexed

About

Kai Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kai Xu has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 30 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Kai Xu's work include RNA modifications and cancer (17 papers), Cancer-related molecular mechanisms research (15 papers) and Osteoarthritis Treatment and Mechanisms (13 papers). Kai Xu is often cited by papers focused on RNA modifications and cancer (17 papers), Cancer-related molecular mechanisms research (15 papers) and Osteoarthritis Treatment and Mechanisms (13 papers). Kai Xu collaborates with scholars based in China, United States and Spain. Kai Xu's co-authors include Lin Ji, Jack A. Roth, Lidong Wu, Safwat Adel Abdo Moqbel, Yuzhe He, John D. Minna, Chiyuan Ma, Jiapeng Bao, Jisheng Ran and Masahiko Nishizaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Kai Xu

110 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Xu China 31 1.7k 626 439 359 283 112 2.8k
Jinyong Luo China 26 2.2k 1.3× 591 0.9× 420 1.0× 329 0.9× 183 0.6× 71 3.4k
Hao Peng China 30 1.2k 0.7× 443 0.7× 273 0.6× 344 1.0× 264 0.9× 126 2.7k
Bin Ma China 26 1.0k 0.6× 374 0.6× 279 0.6× 359 1.0× 484 1.7× 84 2.3k
Zhirong Wang China 28 1.3k 0.8× 373 0.6× 223 0.5× 231 0.6× 180 0.6× 108 2.4k
Young Joo Jeon South Korea 36 2.3k 1.3× 1.0k 1.7× 501 1.1× 220 0.6× 806 2.8× 119 3.8k
Yasuo Kubota Japan 27 1.4k 0.8× 358 0.6× 294 0.7× 157 0.4× 432 1.5× 149 3.3k
Bartholomew J. Votta United States 19 1.4k 0.8× 297 0.5× 569 1.3× 363 1.0× 450 1.6× 30 2.5k
Peter Newham United Kingdom 23 1.2k 0.7× 456 0.7× 231 0.5× 376 1.0× 531 1.9× 38 2.6k
Hongtao Liu China 32 2.0k 1.2× 1.1k 1.8× 720 1.6× 147 0.4× 712 2.5× 96 3.5k

Countries citing papers authored by Kai Xu

Since Specialization
Citations

This map shows the geographic impact of Kai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Xu more than expected).

Fields of papers citing papers by Kai Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Xu. The network helps show where Kai Xu may publish in the future.

Co-authorship network of co-authors of Kai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Xu. A scholar is included among the top collaborators of Kai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Xu. Kai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yilin, et al.. (2024). Causality of blood metabolites and metabolic pathways on peripheral arteriosclerosis: a Mendelian randomization study. Frontiers in Nutrition. 11. 1421531–1421531. 1 indexed citations
3.
Zhang, Fengjuan, Ning Li, Kai Xu, et al.. (2024). CRISPR/Cas: An Emerging Toolbox for Engineering Virus Resistance in Plants. Plants. 13(23). 3313–3313. 6 indexed citations
4.
Wang, Shoujie, Kai Xu, Xiaoling Chen, et al.. (2024). A Retrospective Study for Labia Minora Reduction by Serrated-shaped Resection. Plastic & Reconstructive Surgery Global Open. 12(3). e5634–e5634.
5.
Wu, Zijun, et al.. (2023). Study on the Key Genes and Molecular Mechanisms of IL-27 Promoting Keratinocytes Proliferation Based on Transcriptome Sequencing. Clinical Cosmetic and Investigational Dermatology. Volume 16. 1457–1472. 3 indexed citations
6.
He, Yuzhe, Miao Sun, Jirong Wang, et al.. (2022). Chondroitin sulfate microspheres anchored with drug-loaded liposomes play a dual antioxidant role in the treatment of osteoarthritis. Acta Biomaterialia. 151. 512–527. 70 indexed citations
7.
Bao, Jiapeng, Changjian Lin, Xing Zhou, et al.. (2021). circFAM160A2 Promotes Mitochondrial Stabilization and Apoptosis Reduction in Osteoarthritis Chondrocytes by Targeting miR‐505‐3p and SIRT3. Oxidative Medicine and Cellular Longevity. 2021(1). 5712280–5712280. 20 indexed citations
8.
Zhang, Lei, Zhiqiang Qin, Xian Gao, et al.. (2021). miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9. Frontiers in Oncology. 10. 596574–596574. 7 indexed citations
9.
Xu, Kai, Changjian Lin, Mengyao Chen, et al.. (2021). Spironolactone Ameliorates Senescence and Calcification by Modulating Autophagy in Rat Tendon‐Derived Stem Cells via the NF‐κB/MAPK Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 5519587–5519587. 20 indexed citations
10.
Hu, Min, Yuqing Zheng, Kai Xu, et al.. (2021). Short-Term High-Intensity Interval Exercise Promotes Motor Cortex Plasticity and Executive Function in Sedentary Females. Frontiers in Human Neuroscience. 15. 620958–620958. 14 indexed citations
11.
Wang, Kangning, Kai Xu, Xuefeng Leng, Yongtao Han, & Qiang Fang. (2020). miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR. Technology in Cancer Research & Treatment. 19. 1079213455–1079213455. 10 indexed citations
12.
Xu, Ping, et al.. (2020). Tumour suppressive long non‐coding RNA AFDN‐DT inhibits gastric cancer invasion via transcriptional regulation. Journal of Cellular and Molecular Medicine. 24(5). 3157–3166. 7 indexed citations
13.
Xu, Kai & Ying Feng. (2018). HOXD‐AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer. Journal of Cellular Biochemistry. 120(4). 5326–5332. 12 indexed citations
15.
Lin, Jing, Kai Xu, Jack A. Roth, & Lin Ji. (2016). Detection of siRNA-mediated target mRNA cleavage activities in human cells by a novel stem-loop array RT-PCR analysis. Biochemistry and Biophysics Reports. 6. 16–23. 9 indexed citations
16.
Xu, Kai, Ke Wang, Ying Yang, et al.. (2015). Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome. European Journal of Medicinal Chemistry. 98. 61–68. 6 indexed citations
17.
Xu, Kai. (2012). Effect of Relative Molecular Weight on Properties of β-Form Isotactic Polypropylene. China Plastics. 1 indexed citations
18.
Yarilina, Anna, Kai Xu, Janice Chen, & Lionel B. Ivashkiv. (2011). TNF activates calcium–nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proceedings of the National Academy of Sciences. 108(4). 1573–1578. 115 indexed citations
19.
Lin, Jing, et al.. (2011). Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells. Biochemical and Biophysical Research Communications. 410(2). 235–241. 12 indexed citations
20.
Jayachandran, Gitanjali, Kai Xu, Luc Girard, et al.. (2007). Fragile Histidine Triad–Mediated Tumor Suppression of Lung Cancer by Targeting Multiple Components of the Ras/Rho GTPase Molecular Switch. Cancer Research. 67(21). 10379–10388. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026